Analysis of the thyrotropin receptor-thyrotropin interaction by comparative modeling

Thyroid

Volumn 14, Issue 12, 2004, Pages 991-1011

  Miguel, Ricardo Núñez ^a,b   Sanders, Jane ^a   Jeffreys, Jennifer ^a   Depraetere, Hilde ^a   Evans, Michele ^a   Richards, Tonya ^a   Blundell, Tom L ^b   Smith, Bernard Rees ^a   Furmaniak, Jadwiga ^a  

^a RSR LTD   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; DISULFIDE; FOLLITROPIN; GLUTAMIC ACID; LEUCINE; LYSINE; MEMBRANE PROTEIN; MONOCLONAL ANTIBODY; RHODOPSIN; THYROTROPIN RECEPTOR; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ALPHA CHAIN; ALPHA HELIX; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CHEMICAL MODEL; COMPARATIVE STUDY; CONTROLLED STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; THYROID FUNCTION;

ANIMALS; ANTIBODIES, MONOCLONAL; EPITOPES; HUMANS; HYDROGEN BONDING; IMMUNOGLOBULIN FAB FRAGMENTS; LEUCINE; LIGANDS; MEMBRANES; MICE; MICE, INBRED BALB C; MODELS, BIOLOGICAL; MODELS, MOLECULAR; RECEPTORS, THYROTROPIN; RNA; THYROTROPIN;

EID: 11344254774     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2004.14.991     Document Type: Article

References (88)

1. Rees Smith B, McLachlan SM, Furmaniak J 1988 Autoantibodies to the thyrotropin receptor. Endocr Rev 9:106-121.
2. Rapoport B, Chazenbalk GD, Jaume JC, McLachlan SM 1998 The thyrotropin (TSH) receptor: Interaction with TSH and autoantibodies. Endocr Rev 19:673-716.
3. Jeffreys J, Depraetere H, Sanders J, Oda Y, Evans M, Kiddie A, Richards, T, Furmaniak J, Rees Smith B 2002 Characterization of the thyrotropin binding pocket. Thyroid 12:1051-1061.
4. Sanders J, Jeffreys J, Depraetere H, Richards T, Evans M, Kiddie A, Brereton K, Groenen M, Oda Y, Furmaniak J, Rees Smith B 2002 Thyroid-stimulating monoclonal antibodies. Thyroid 12:1043-1050.
5. Sanders J, Evans M, Premawardhana LDKE, Depraetere H, Jeffreys J, Richards T, Furmaniak J, Rees Smith B 2003 Human monoclonal thyroid stimulating autoantibody. Lancet 362:126-128.
6. Kajava AV, Vassart G, Wodak SJ 1995 Modeling of the three-dimensional structure of proteins with the typical leucine-rich repeats. Structure 3:867-877.
7. Jiang X, Dreano M, Buckler DR, Cheng S, Ythier A, Wu H, Hendrickson WA, Tayar NE 1995 Structural predictions for the ligand-binding region of glycoprotein hormone receptors and the nature of hormone-receptor interactions. Structure 3:1341-1353.
8. Biebermann H, Schoneberg T, Schulz A, Krause G, Gruters A, Schultz G, Gudermann T 1998 A conserved tyrosine residue (Y601) in transmembrane domain 5 of the human thyrotropin receptor serves as a molecular switch to determine G-protein coupling. FASEB J 12:1461-1471.
9. Neumann S, Krause G, Chey S, Paschke R 2001 A free carboxylate oxygen in the side chain of position 674 in transmembrane domain 7 is necessary for TSH receptor activation. Mol Endocrinol 15:1294-1305.
10. Miguel RN, Sanders J, Jeffreys J, Depraetere H, Blundell TL, Furmaniak J, Rees Smith B 2003 Thyrotropin receptor cleavage domain and tissue inhibitor of metalloproteinase-2. Thyroid 13:665-666.
11. Prentice L, Kiso Y, Fukuma N, Horimoto M, Petersen V, Grennan F, Pegg C, Furmaniak J, Rees Smith B 1995 Monoclonal thyroglobulin autoantibodies: Variable region analysis and epitope recognition. J Clin Endocrinol Metab 80:977-986.
12. Oda Y, Sanders J, Roberts S, Maruyama M, Kato R, Perez M, Petersen VB, Wedlock N, Furmaniak J, Rees Smith B 1998 Binding characteristics of antibodies to the TSH receptor. J Mol Endocrinol 20:233-244.
13. Chomczynski P, Sacchi N 1987 Single-step method of RNA isolation by guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159.
14. Kettleborough CA, Saldanha J, Ansell KH, Bendig MM 1993 Optimization of primers for cloning libraries of mouse immunoglobulin genes using the polymerase chain reaction. Eur J Immunol 23:206-211.
15. Reineke U, Kramer A, Schneider-Mergener J 1999 Antigen sequence- and library-based mapping of linear and discontinuous protein-protein-interaction sites by spot synthesis. Curr Top Microbiol Immunol 243:23-36.
16. Fiddes JC, Goodman HM 1981 The gene encoding the common alpha subunit of the four human glycoprotein hormones. J Mol Appl Genet 1:3-18.
17. Goodwin RG, Moncman CL, Rottman FM, Nilson JH 1983 Characterization and nucleotide sequence of the gene for the common alpha subunit of the bovine pituitary glycoprotein hormones. Nucleic Acids Res 11:6873-6882.
18. Maurer RA, Croyle ML, Donelson JE 1984 The sequence of a cloned cDNA for the beta subunit of bovine thyrotropin predicts a protein containing both NH2- and COOH-terminal. J Biol Chem 259:5024-5027.
19. Hayashizaki Y, Miyai K, Kato K, Matsubara K 1985 Molecular cloning of the human thyrotropin-beta subunit gene. FEBS Lett 188:394-400.
20. Hirai T, Takikawa H, Kato Y 1989 Molecular cloning of cDNAs for precursors of porcine pituitary glycoprotein hormone common alpha-subunit and of thyroid stimulating hormone beta-subunit. Mol Cell Endocrinol 63:209-217.
21. Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ 1997 Gapped BLAST and PSI-BLAST: A new generation of protein database search programs. Nucleic Acids Res 25:3389-3402.
22. Lichtarge O, Bourne HR, Cohen FE 1996 An evolutionary trace method defines binding surfaces common to protein families. J Mol Biol 257:342-358.
23. Innis CA, Shi J, Blundell TL 2000 Evolutionary trace analysis of TGB-β and related growth factors: Implications for site-directed mutagenesis. Protein Eng 13:839-847.
24. Wu H, Lustbader JW, Liu Y, Canfield RE, Hendrickson WA 1994 Structure of human chorionic gonadotropin at 2.6 angstroms resolution from MAD analysis of the selenomethionyl protein. Structure 2:545-558.
25. Fox KM, Dias JA, vanRoey P 2001 Three-dimensional structure of human follicle-stimulating hormone. Mol Endocrinol 15:378-389.
26. Nagayama Y, Kaufman KD, Seto P, Rapoport B 1989 Molecular cloning, sequence and functional expression of the cDNA for the human thyrotropin receptor. Biochem Biophys Res Commun 165:1184-1190.
27. Misrahi M, Loosfelt H, Atger M, Sar S, Guiochon-Mantel A, Milgrom E 1990 Cloning, sequencing and expression of human TSH receptor. Biochem Biophys Res Commun 166:394-403.
28. Fischer D 2000 Hybrid fold recognition: combining sequence derived properties with evolutionary information. In: Pacific Symp Biocomputing, January 4-9, 2000, Island of Oahu, Hawaii, pp. 119-130.
29. Shi J, Blundell TL, Mizuguchi K 2001 FUGUE: sequence-structure homology recognition using environment-specific substitution tables and structure-dependent gap penalties. J Mol Biol 310:243-257.
30. Sali A, Blundell TL 1993 Comparative protein modeling by satisfaction of spatial restraints. J Mol Biol 234:779-815.
31. Laskowski RA, MacArthur MW, Moss DS, Thornton JM 1993 PROCHECK - A program to check the stereochemical quality of protein structures. J Appl Crystallogr 26:283-291.
32. Luthy R, Bowie JU, Eisenberg D 1992 Assessment of protein models with 3-dimensional profiles. Nature 356:83-85.
33. Mizuguchi K, Deane CM, Blundell TL, Johnson MS, Overington JP 1998 JOY: Protein sequence-structure representation and analysis. Bioinformatics 14:617-623.
34. Deane CM, Blundell TL 2001 CODA: A combined algorithm for predicting the structurally variable regions of protein models. Protein Sci 10:599-612.
35. de Bakker PI, DePristo MA, Burke DF, Blundell TL 2003 Ab initio construction of polypeptide fragments: Accuracy of loop decoy discrimination by an all-atom statistical potential and the AMBER force field with Generalized Born solvation model. Proteins Struct Funct Genet 51:21-40.
36. DePristo MA, deBakker PIW, Lovell SC, Blundell TL 2003 Ab initio construction of polypeptide fragments: Efficient generation of consistent, representative ensembles. Proteins Struct Funct Genet 51:41-55.
37. SYBYL 1997 6.5 edition. Trypos Inc., St Louis, MO.
38. Jones S, Thornton JM 1996 Principles of protein-protein interactions. Proc Natl Acad Sci USA 93:13-20.
39. Lee B, Richards FM 1971 The interpretation of protein structures: Estimation of static accessibility. J Mol Biol 55:379-400.
40. Richmond TJ 1984 Solvent accessible surface area and excluded volume in proteins. Analytical equations for overlapping spheres and implications for the hydrophobic effect. J Mol Biol 178:63-89.
41. McDonald IK, Thornton JM 1994 Satisfying hydrogen bonding potential in proteins. J Mol Biol 238:777-793.
42. Nicholls A, Sharp K, Honing B 1991 Protein folding and association: Insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins 11:281-296.
43. Sutcliffe MJ, Haneef I, Carney D, Blundell TL 1987 Knowledge based modeling of homologous proteins, part I: Three-dimensional frameworks derived from the simultaneous superposition of multiple structures. Protein Eng 1:377-384.
44. Katchalski-Katzir E, Shariv I, Eisestein M, Friesem AA, Aflalo C, Vakser IA 1992 Molecular surface recognition: Determination of geometric fit between proteins and their ligands by correlation techniques. Proc Natl Acad Sci USA 89:2195-2199.
45. Sayle RA, Milner-White EJ 1995 RasMol-Biomolecular graphics for all. Trends Biochem Sci 20:374-376.
46. Oda Y, Sanders J, Evans M, Kiddie A, Munkley A, James C, Richards T, Wills J, Furmaniak J, Rees Smith B 2000 Epitope analysis of the human monoclonal thyrotropin (TSH) receptor using monoclonal antibodies. Thyroid 10:1051-1059.
47. Kabat E, Perry H, Wu T, Gottesman K, Foeller C 1991 Sequences of Proteins of Immunological Interest, 5th ed. U.S. Public Health Service, Bethesda, MD.
48. McDonald NQ, Hendrickson WA 1993 A structural superfamily of growth factors containing & cystine knot motif. Cell 73:421-424.
49. Murray-Rust J, McDonald NQ, Blundell TL, Hosang M, Oefner C, Winkler F, Bradshaw RA 1993 Topological similarities in TGF-beta 2, PDGF-BB and NGF define a superfamily of polypeptide growth factors. Structure 1:153-159.
50. Buchanan SG, Gay NJ 1996 Structural and functional diversity in the leucine-rich repeat family of proteins. Prog Biophys Mol Biol 65:1-44.
51. Kobe B, Deisenhofer J 1993 Crystal structure of porcine ribonuclease inhibitor, a protein with leucine-rich repeats. Nature 366:751-756.
52. de Bernard S, Misrahi M, J-C H, Milgrom E 1999 Sequential cleavage and excision of a segment of the thyrotropin receptor ectodomain. J Biol Chem 274:101-107.
53. Tuuttila A, Morgunova E, Bergmann U, Lindqvist Y, Tryggvason K, Schneider G 1998 Three-dimensional structure of human tissue inhibitor of metalloproteinases-2 at 2.1 Å resolution. J Mol Biol 284:1133-1140.
54. Murzin AG 1993 OB (oligonucleotide/oligosaccharide binding)-fold: Common structural and functional solution for non-homologous sequences. EMBO J 12:861-867.
55. Palczewski K, Kamusaka T, Hori T, Behnke CA, Motoshima H, Fox BA, LeTrong I, Teller DC, Okada T, Stenkamp RE, Yamamoto M, Miyano M 2000 Crystal structure of rhodopsin: A G protein-coupled receptor. Science 289:739-745.
56. Okada T, Fujiyoshi Y, Silow M, Navarro J, Landau EM, Shichida Y 2002 Functional role of internal water molecules in rhodopsin revealed by x-ray crystallography. Proc Natl Acad Sci USA 95:12854-12859.
57. Konig B, Arendt A, McDowell JH, Kahlert M, Hargrave PA, Hofmann KP 1989 3 Cytoplasmatic loops of rhodopsin interact with transducin. Proc Natl Acad Sci USA 86:6878-6882.
58. Lescar J, Stouracova R, Riottot MM, Chitarra V, Brynda J, Fabry M, Horejsi M, Sedlacek J, Bentley GA 1997 Three-dimensional structure of an Fab-peptide complex: Structural basis of HIV-1 protease inhibition by a monoclonal antibody. J Mol Biol 267:1207-1222.
59. Golinelli-Pimpaneau B, Goncalves O, Dintinger T, Blanchard D, Knossow M, Tellier C 2000 Structural evidence for a programmed general base in the active site of a catalytic antibody. Proc Natl Acad Sci USA 97:9892-9895.
60. Szkudlinski MW, Teh NG, Grossmann M, Tropea JE, Weintraub BD 1996 Engineering human glycoprotein hormone superactive analogues. Nature Biotech 14:1257-1263.
61. Duprez L, Parma J, Costagliola S, Hermans J, Van-Sande J, Dumont JE, Vassart G 1997 Constitutive activation of the TSH receptor by spontaneous mutations affecting the N-terminal extracellular domain. FEBS Letters 409:469-474.
62. Gruters A, Schoneberg T, Biebermann H, Krude H, Krohn HP, Dralle H, Gudermann T 1998 Severe congenital hyperthyroidism caused by a germ-line neo mutation in the extracellular portion of the thyrotropin receptor. J Clin Endocrinol Metab 83:1431-1436.
63. Szkudlinski MW, Fremont V, Ronin C, Weintraub BD 2002 Thyroid-stimulating hormone and thyroid-stimulating hormone receptor structure-function relationships. Physiol Rev 82:473-502.
64. Vlaeminck-Guillem V, Ho S-C, Rodien P, Vassart G, Costagliola S 2002 Activation of the cAMP pathway by the TSH receptor involves switching of the ectodomain from a tethered inverse agonist to an agonist. Mol Endocrinol 16:736-746.
65. Smits G, Govaerts C, Nubourgh I, Pardo L, Vassart G, Costagliola S 2002 Lysine 183 and glutamic acid 157 of the TSH receptor: Two interacting residues with a key role in determining specificity toward TSH and human CG. Mol Endocrinol 16:722-735.
66. Brooks BR, Bruccolesi RE, Olafson BD, States DJ, Swaminathan S, Karplus M 1983 CHARMM: A program for macromolecular energy minimisation and dynamics calculations. J Comp Chem 4:187-217.
67. Press WH, Flannery BP, Teukolsky SA, Vetterling WT 1986 Numerical Recipes. Cambridge University Press, Cambridge.
68. Kajava AV 1998 Structural diversity of leucine-rich repeat proteins. J Mol Biol 277:519-527.
69. Chen C-R, Tanaka K, Chazenbalk GD, McLachlan SM, Rapoport B 2001 A full biological response to autoantibodies in Graves' disease requires a disulfide-bonded loop in the thyrotropin receptor N terminus homologous to a laminin epidermal growth factor-like domain. J Biol Chem 276:14767-14772.
70. Kobe B, Deisenhofer J 1994 The leucine-rich repeat: A versatile binding motif. Trends Biochem Sci 19:415-421.
71. Dufau ML 1998 The luteinizing hormone receptor. Annu Rev Physiol 60:461-496.
72. Chazenbalk GD, McLachlan SM, Nagayama Y, Rapoport B 1996 Is receptor cleavage into two subunits necessary for thyrotropin action? Biochem Biophys Res Commun 225:479-484.
73. Unger VM, Hargrave PA, Baldwin JM, Schertler GF 1997 Arrangement of rhodopsin transmembrane α-helices. Nature 389:203-206.
74. Wonerow P, Neumann S, Gudermann T, Paschke R 2001 Thyrotropin receptor mutations as a tool to understand thyrotropin receptor action. J Mol Med 79:707-721.
75. Claeysen S, Govaerts C, Lefort A, Van Sande J, Costagliola S, Pardo L, Vassart G 2002 A conserved Asn in TM7 of the thyrotropin receptor is a common requirement for activation by both mutations and its natural agonist. FEBS Lett 517:196-200.
76. Smits G, Campillo M, Govaerts C, Janssens V, Richter C, Vassart G, Pardo L, Costagliola S 2003 Glycoprotein hormone receptors: Determinants in leucine-rich repeats responsible for ligand specificity. EMBO J 22:2692-2703.
77. Grossmann M, Szkudlinski MW, Dias JA, Xia HY, Wong R, Puett D, Weintraub BD 1996 Site-directed mutagenesis of amino acids 33-44 of the common alpha-subunit reveals different structural requirements for heterodimer expression among the glycoprotein hormones and suggests that cyclic adenosine 3′,5′-monophosphate production and growth promotion are potentially dissociable functions of human thyrotropin. Mol Endocrinol 10:769-779.
78. Costagliola S, Panneels V, Bonomi M, Koch J, Many MC, Smits G, Vassart G 2002 Tyrosine sulfation is required for agonist recognition by glycoprotein hormone receptors. EMBO J 21:504-513.
79. Latif R, Graves P, Davies TF 2001 Oligomerization of the human thyrotropin receptor. J Biol Chem 276:45217-45224.
80. Davies T, Marians R, Latif R 2002 The TSH receptor reveals itself. J Clin Invest 110:161-164.
81. Kaczur V, Puskás LG, Takács M, Rácz IA, Szendröi A, Tóth S, Nagy Z, Szalai C, Balázs C, Falus A, Knudsen B, Farid N 2003 Evolution of the thyrotropin receptor: A G protein coupled receptor with an intrinsic capacity to dimerize. Mol Genet Metab 78:275-290.
82. Fotiadis D, Liang Y, Filipek S, Saperstein DA, Engel A, Palczewski K 2003 Rhodopsin dimers in native disc membranes. Nature 421:127-128.
83. Padlan EA 1990 On the nature of antibody combining sites: Unusual structural features that may confer on these sites an enhanced capacity for binding ligands. Proteins 7:112-124.
84. Hendry E, Taylor G, Grennan-Jones F, Sullivan A, Liddy N, Godfrey J, Hayakawa N, Powell M, Sanders J, Furmaniak J, Rees Smith B 2001 X-ray crystal structure of a monoclonal antibody that binds to a major autoantigenic epitope on thyroid peroxidase. Thyroid 11:1091-1099.
85. Zhang M, Tong K, Fremont V, Chen J, Narayan P, Puett D, Weintraub B, Szkudlinski M 2000 The extracellular domain suppresses constitutive activity of the transmembrane domain of the human TSH receptor: Implications for hormonereceptor interaction and antagonist design. Endocrinology 141:3514-3517.
86. Chen C-R, Chazenbalk GD, McLachlan SM, Rapoport B 2003 Evidence that the C terminus of the A subunit suppresses thyrotropin receptor constitutive activity. Endocrinology 144:3821-3827.
87. Williams MG, Shirai H, Shi J, Nagendra HG, Mueller J, Mizuguchi K, Miguel RN, Lovell SC, Innis CA, Deane CM, Chen L, Campillo N, Burke DF, Blundell TL, de Bakker PIW 2001 Sequence-structure homology recognition by iterative alignment refinement and comparative modelling. Proteins Suppl 5:92-97.
88. Miguel RN, Shi J, Mizuguchi K 2001 Protein Fold Recognition and Comparative Modeling using HOSTRAD, JOY and FUGUE. In: Tsigelny I (ed) Protein Structure Prediction: Bioinformatic Approach. International University Line (IUL), La Jolla, pp. 143-169.